Advances in Vaccines for Melanoma

被引：2
|
作者：
Cui, Can [1 ,2 ]
Ott, Patrick A. [2 ,3 ,4 ,5 ]
Wu, Catherine J. [2 ,3 ,4 ,5 ]
机构：
[1] Massachusetts Gen Hosp, Dept Med, Boston, MA USA
[2] Harvard Med Sch, Boston, MA 02115 USA
[3] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA
[4] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA
[5] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2024年 / 38卷 / 05期
关键词：
Melanoma; Neoantigen; Personalized cancer vaccine; Immunotherapy; TUMOR MUTATIONAL BURDEN; CELL-BASED IMMUNOTHERAPY; CYTOLYTIC T-LYMPHOCYTES; CLINICAL-RESPONSE; SOLID TUMORS; CANCER; IPILIMUMAB; NIVOLUMAB; PEMBROLIZUMAB; BLOCKADE;
D O I：
10.1016/j.hoc.2024.05.009
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1045 / 1060
页数：16
相关论文
共 50 条
  • [21] Primary tumor characteristics and next-generation sequencing mutations as biomarkers for melanoma immunotherapy response
    Loo, Kimberly
    Gauvin, Gabrielle
    Soliman, Iman
    Renzetti, Madelyn
    Deng, Mengying
    Ross, Eric
    Luo, Biao
    Wu, Hong
    Reddy, Sanjay
    Olszanski, Anthony J.
    Farma, Jeffrey M.
    PIGMENT CELL & MELANOMA RESEARCH, 2020, 33 (06) : 878 - 888
  • [22] Immune therapy of melanoma: Overview of therapeutic vaccines
    Payandeh, Zahra
    Yarahmadi, Maral
    Nariman-Saleh-Fam, Ziba
    Tarhriz, Vahideh
    Islami, Maryam
    Aghdam, Abdolreza Mehdinavaz
    Eyvazi, Shirin
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (09) : 14612 - 14621
  • [23] Immunotherapy and delivery systems for melanoma
    Liu, Hui
    Gou, Xi
    Tan, Yuanfang
    Fan, Qiuying
    Chen, Juanjuan
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)
  • [24] Getting personal in metastatic melanoma: neoantigen-based vaccines as a new therapeutic strategy
    D'Alise, Anna Morena
    Scarselli, Elisa
    CURRENT OPINION IN ONCOLOGY, 2023, 35 (02) : 94 - 99
  • [25] Recent advances in immunotherapy and its combination therapies for advanced melanoma: a review
    Xu, Jiamin
    Mu, Shukun
    Wang, Yun
    Yu, Suchun
    Wang, Zhongming
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [26] Surgical Management of Melanoma: Advances and Updates
    Santamaria-Barria, Juan A.
    Mammen, Joshua M., V
    CURRENT ONCOLOGY REPORTS, 2022, 24 (11) : 1425 - 1432
  • [27] Inhibitors of Cytotoxic T Lymphocyte Antigen 4 and Programmed Death 1/Programmed Death 1 Ligand for Metastatic Melanoma, Dual Versus Monotherapy-Summary of Advances and Future Directions for Studying These Drugs
    Loo, Kimberly
    Daud, Adil I.
    CANCER JOURNAL, 2017, 23 (01) : 3 - 9
  • [28] Uveal melanoma: Recent advances in immunotherapy
    Sorrentino, Francesco Saverio
    De Rosa, Francesco
    Di Terlizzi, Patrick
    Toneatto, Giacomo
    Gabai, Andrea
    Finocchio, Lucia
    Salati, Carlo
    Spadea, Leopoldo
    Zeppieri, Marco
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2024, 15 (01):
  • [29] Recent Advances in the Management of Malignant Melanoma
    Chedid, Marcio F.
    Mattei, Jane
    CURRENT PHARMACEUTICAL DESIGN, 2024,
  • [30] The Risk of Diarrhea and Colitis in Patients With Advanced Melanoma Undergoing Immune Checkpoint Inhibitor Therapy: A Systematic Review and Meta-Analysis
    Tandon, Parul
    Bourassa-Blanchette, Samuel
    Bishay, Kirles
    Parlow, Simon
    Laurie, Scott A.
    McCurdy, Jeffrey D.
    JOURNAL OF IMMUNOTHERAPY, 2018, 41 (03) : 101 - 108
12345